The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Aspergillus Galactomannan Detection in the Diagnosis of Invasive Aspergillosis in Cancer Patients
Abstract
PURPOSE: To assess the Aspergillus galactomannan enzyme-linked immunosorbent assay (ELISA) in the diagnosis of invasive aspergillosis (IA) in adult and pediatric oncohematologic patients. PATIENTS AND METHODS: The study was conducted in four patient groups: those with fever of unknown origin (FUO) during neutropenia, suspected pulmonary infection (PI), or nonpulmonary aspergillosis (NPA) and those undergoing surveillance (S) after hematopoietic stem-cell transplantation (HSCT). IA was classified as definite, probable, or possible, according to European Organization for Research and Treatment of Cancer/Mycosis Study Group definitions. RESULTS: A total of 3,294 serum samples were collected during 797 episodes (FUO, 261; PI, 297; NPA, 28; and surveillance, 211), and 153 episodes of IA were diagnosed (31 definite, 67 probable, and 55 possible). Three episodes were first suspected from galactomannan ELISA; the remaining 150 cases were diagnosed from clinical or radiologic evidence. Sensitivity of the ELISA was 64.5%, 16.4%, and 25.5% in definite, probable, and possible episodes of IA, respectively, and was lower in patients positive for anti-Aspergillus antibodies than in antibody-negative patients. Most false-positive results occurred in children and in allogeneic HSCT (allo-HSCT) patients. Overall specificity of the ELISA was 94.8%. It was lower in children compared with adults (P < .0001) and in allo-HSCT patients compared with non–allo-HSCT adults (P = .0002). Lowering the ELISA cutoff value from 1.500 to 0.700 seemed more relevant for non–allo-HSCT adults (sensitivity, 73.1%, 44.3%, and 44.7% in definite, probable, and possible IA, respectively; specificity, 94%). CONCLUSION: Galactomannan ELISA seems less sensitive than previously described, and sensitivity can be further reduced by the presence of anti-Aspergillus antibodies. A new cutoff value for the ELISA of 0.700 is proposed for non–allo-HSCT adults.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ascioglu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Bille, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/323335 · Cited by 2,331
Practice Guidelines for Diseases Caused by Aspergillus
Stevens, D. A., Kan, V. L., Judson, M. A., Morrison, V. A., Dummer, S., Denning, D. W., Bennett, J. E., Walsh, T. J., Patterson, T. F., & Pankey, G. A. (2000) · Clinical Infectious Diseases · doi:10.1086/313756 · Cited by 789
Caillot, D., Casasnovas, O., Bernard, A., Couaillier, J. F., Durand, C., Cuisenier, B., Solary, E., Piard, F., Petrella, T., Bonnin, A., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.139 · Cited by 706
Maertens, J., Verhaegen, J., Lagrou, K., Van Eldere, J., & Boogaerts, M. (2001) · Blood · doi:10.1182/blood.v97.6.1604 · Cited by 513
Maertens, J., Verhaegen, J., Demuynck, H., Brock, P., Verhoef, G., Vandenberghe, P., Van Eldere, J., Verbist, L., & Boogaerts, M. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.10.3223-3228.1999 · Cited by 376
Pulmonary Aspergillosis: Early Diagnosis Improves Survival
von Eiff, M., Roos, N., Schulten, R., Hesse, M., Zühlsdorf, M., & van de Loo, J. (1995) · Respiration · doi:10.1159/000196477 · Cited by 351
Stynen, D., Goris, A., Sarfati, J., & Latgé, J. P. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.2.497-500.1995 · Cited by 330
The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis
Horvath, J. A., & Dummer, S. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)89455-7 · Cited by 323
Sulahian, A., Boutboul, F., Ribaud, P., Leblanc, T., Lacroix, C., & Derouin, F. (2001) · Cancer · doi:10.1002/1097-0142(20010115)91:2<311::aid-cncr1003>3.0.co;2-3 · Cited by 226
Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan
Swanink, C. M., Meis, J. F., Rijs, A. J., Donnelly, J. P., & Verweij, P. E. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.1.257-260.1997 · Cited by 222
Sendid, B., Tabouret, M., Poirot, J. L., Mathieu, D., Fruit, J., & Poulain, D. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.5.1510-1517.1999 · Cited by 202
Verweij, P. E., Stynen, D., Rijs, A. J., de Pauw, B. E., Hoogkamp-Korstanje, J. A., & Meis, J. F. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.7.1912-1914.1995 · Cited by 192
Sulahian, A., Tabouret, M., Ribaud, P., Sarfati, J., Gluckman, E., Latgé, J. P., & Derouin, F. (1996) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01591487 · Cited by 183
Bretagne, S., Marmorat‐Khuong, A., Kuentz, M., Latgé, J., Bart–Delabesse, E., & Cordonnier, C. (1997) · Journal of Infection · doi:10.1016/s0163-4453(97)90833-1 · Cited by 129
Fortün, J., Martín‐Dávila, P., Alvarez, M. E., Sánchez-Sousa, A., Quereda, C., Navas, E., Bárcena, R., Vicente, E., Candelas, A., Honrubia, A., et al. (2001) · Transplantation · doi:10.1097/00007890-200101150-00023 · Cited by 112
Early diagnosis of invasive aspergillosis
Denning, D. W. (2000) · The Lancet · doi:10.1016/s0140-6736(00)82003-6 · Cited by 89
Machetti, M., Feasi, M., Mordini, N., Lint, M. V., Bacigalupo, A. P., Latgé, J.-P., Sarfati, J., & Viscoli, C. (1998) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1701206 · Cited by 88
Siemann, M., Koch‐Dörfler, M., & Gaude, M. (1998) · Mycoses · doi:10.1111/j.1439-0507.1998.tb00356.x · Cited by 86
Receptor-Mediated Clearance of Aspergillus Galactomannan
Bennett, J. E., Friedman, M. M., & Dupont, B. (1987) · The Journal of Infectious Diseases · doi:10.1093/infdis/155.5.1005 · Cited by 82
Verweij, P. E., Meis, J. F. G. M., Dompeling, E., Donnelly, J. P., & Schattenberg, A. (1997) · Infection · doi:10.1007/bf02113581 · Cited by 79
Evaluation of eight antibody tests and one antigen test for the diagnosis of invasive aspergillosis
Kappe, R., Schulze‐Berge, A., & Sonntag, H. (1996) · Mycoses · doi:10.1111/j.1439-0507.1996.tb00078.x · Cited by 62
Fungal infections in patients undergoing blood and marrow transplantation
Marr, K. A., & Bowden, R. A. (1999) · Transplant Infectious Disease · doi:10.1034/j.1399-3062.1999.010403.x · Cited by 62
Aspergillus antigen testing in bone marrow transplant recipients
Williamson, E. C. M., Oliver, D. A., Johnson, E. M., Foot, A. B. M., Marks, D. I., & Warnock, D. W. (2000) · Journal of Clinical Pathology · doi:10.1136/jcp.53.5.362 · Cited by 41
Cited by
Freifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J.-A. H., & Wingard, J. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir073 · Cited by 3,463
Patterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Nguyen, M. H., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw326 · Cited by 2,926
Self-citationWalsh, T. J., Anaissie, E. J., Denning, D. W., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Segal, B. H., Steinbach, W. J., Stevens, D. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/525258 · Cited by 2,706
Self-citationDiagnosis of Invasive Aspergillosis Using a Galactomannan Assay: A Meta-Analysis
Pfeiffer, C. D., Fine, J. P., & Safdar, N. (2006) · Clinical Infectious Diseases · doi:10.1086/503427 · Cited by 962
Pulmonary aspergillosis: a clinical review
Kousha, M., Tadi, R., & Soubani, A. O. (2011) · European Respiratory Review · doi:10.1183/09059180.00001011 · Cited by 752
Metadata
- Authors
- Herbrecht, R., Letscher-Bru, V., Oprea, C., Lioure, B., Waller, J., Campos, F., Villard, O., Liu, K.-L., Natarajan-Amé, S., Lutz, P., Dufour, P., Bergerat, J.-P., & Candolfi, E.
- Venue
- Journal of Clinical Oncology
- Published
- 2002-04-01
- Volume
- 20
- Issue
- 7
- Pages
- 1898-1906
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2167506258
- Cited by
- 392
- References
- 23
- FWCI
- 18.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.